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Abstract
Background: Atherosclerosis is one of the major complications of type 2 diabetic patients (T2DM), leading to morbidity and
mortality. Grape seed procyanidin B2 (GSPB2) has demonstrated protective effect against atherosclerosis, which is believed
to be, at least in part, a result of its antioxidative effects. The aim of this study is to identify the target protein of GSPB2
responsible for the protective effect against atherosclerosis in patients with DM.
Methods and Results: GSPB2 (30 mg/kg body weight/day) were administrated to db/db mice for 10 weeks. Proteomics of
the aorta extracts by iTRAQ analysis was obtained from db/db mice. The results showed that expression of 557 proteins
were either up- or down-regulated in the aorta of diabetic mice. Among those proteins, 139 proteins were normalized by
GSPB2 to the levels comparable to those in control mice. Among the proteins regulated by GSPB2, the milk fat globule
epidermal growth factor-8 (MFG-E8) was found to be increased in serum level in T2DM patients; the serum level of MFG-E8
was positively correlated with carotid-femoral pulse wave velocity (CF-PWV). Inhibition of MFG-E8 by RNA interference
significantly suppressed whereas exogenous recombinant MFG-E8 administration exacerbated atherogenesis the db/db
mice. To gain more insights into the mechanism of action of MFG-E8, we investigated the effects of MFG-E8 on the signal
pathway involving the extracellular signal-regulated kinase (ERK) and monocyte chemoattractant protein-1 (MCP-1).
Treatment with recombinant MFG-E8 led to increased whereas inhibition of MFG-E8 to decreased expression of MCP-1 and
phosphorylation of ERK1/2.
Conclusion: Our data suggests that MFG-E8 plays an important role in atherogenesis in diabetes through both ERK and
MCP-1 signaling pathways. GSPB2, a well-studied antioxidant, significantly inhibited the arterial wall changes favoring
atherogenesis in db/db mice by down-regulating MFG-E8 expression in aorta and its serum level. Measuring MFG-E8 serum
level could be a useful clinical surrogate prognosticating atherogenesis in DM patients.
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Introduction
Vascular complications are the major cause of morbidity and
mortality in patients with T2DM [1]. The hallmarks of
macrovascular damage are accelerated atherosclerosis and
remodeling of large arteries characterized by thickening and
stiffening of the arterial wall [2,3]. Thus far, there is no cure
available for T2DM and its cardiovascular complications.
Therefore, elucidation of the underlying molecular mechanism
of atherosclerosis associated with T2DM and identification of the
target protein critically involved in this process could lead to a
more specific strategy in fighting against the vascular complica-
tions of T2DM.
The induction of oxidative stress, especially the reactive oxygen
species (ROS) plays a critical role in the development of diabetic
complications [4,5]. Procyanidins are a complex family of
polyphenol polymers widely existing in natural products such as
grape wines, fruits and vegetables [6,7]. Grape seed proanthocya-
nidin extracts (GSPE) derived from grape seeds. Dimeric
procyanidin B2 is one of the main components of GSPE,
composed of two molecules of the flavan-3-ol (-)-epicatechin
linked by a 4bR8 bonds. Studies including ours have shown that
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procyanidin B2 has anti-inflammation, anti-tumor and cardiovas-
cular protective properties, which are believed at least in part, to
result from the antioxidative effects [8–12]. Our previous data
showed that GSPB2 could prevent AGEs-induced ROS genera-
tion, inhibit the human umbilical vein endothelial cell (HUVEC)
apoptosis, AGE-induced proliferation and migration of human
aortic smooth muscle cells (HASMCs) [13–15]. These data suggest
that GSPB2 could exert protective effect on the development of
atherosclerosis in T2DM.
In an effort to understand the underlying molecular mecha-
nisms and identify the potential target protein molecule in
atherogenesis in T2DM, we resorted to proteomic comparative
analyses of the aorta using db/db diabetic mice. db/db mice are
well-established animal model to study T2DM complications. The
quantitative proteomics using isobaric tags for relative and
absolute quantification (iTRAQ) technique enables the detection
and quantitation of proteins, including the hydrophobicity and
high molecular masses of proteins. We found that expression of
557 proteins was altered in the aorta of db/db mice and 139
proteins among them including MFG-E8 were normalized by
GSPB2 to the levels comparable to those in control mice. Our data
suggest that MFG-E8 is a target protein of GSPB2 and plays an
important role in atherogenesis in T2DM.
Materials and Methods
Detailed materials and methods are described in Materials and
Methods S1.
Materials
GSPB2 (more than 90% pure, Lot No: 20100915) was
purchased from Jianfeng Inc (Tianjin, China). Anti-mouse
MFG-E8 antibody was purchased from Abcam (Cambridge,
USA). Anti-human MFG-E8 antibodies and recombinant human
MFG-E8 were purchased from R&D Systems (Minneapolis, USA).
Anti-human MFG-E8 polyclonal antibody was purchased from
Santa Cruz Biotechnology (Santa Cruz, USA). The ELISA kit of
MCP-1 was purchased from eBioscience (Ssn Diego, USA). 8-plex
isobaric tags for relative and absolute quantification (iTRAQ)
protein labeling kit/reagents were purchased from Applied
Biosystems (CA, USA). All other reagents used were standard
commercial high-purity materials.
Animals
Male C57BLKS/J db/db and db/m mice (n = 24, 7 weeks old)
were purchased from Model Animal Research Center of Nanjing
University (Jiangsu, China). They were housed in standard animal
cages and received laboratory pellet chow and tap water ad
libitum in a constant environment (room temperature 20–22uC,
room humidity 40–60%) with a 12-h light, 12-h dark cycle. The
mice were acclimated in the animal housing facility for one week
prior to the start of the experiments. All procedures followed were
in accordance with the standards set forth in the Guide for the Care
and Use of Laboratory Animals and were approved by the animal
ethics committee of Shandong University. C57BLKS/J db/m
mice were selected as control group (CC, n = 8). The db/db mice
were divided into 2 groups: an untreated diabetic group (DM,
n = 8) and GSPB2-treated group (30 mg/kg body weight/day,
DMT, n = 8). GSPB2 was given diluted in normal saline solution
by intragastric administration for 10 weeks. Each group of mice
was observed from week 7 to week 18 without any hypoglycemic
therapy. At the end of the experiments, all mice were fasted
overnight and then sacrificed under sodium pentobarbital
anesthesia. Fasting blood was collected, and the aortas were
dissected. Aortic tissues and sera were kept at 280uC until further
analysis.
Estimation of Body Weight, Fasting Blood Glucose (FBG),
Blood Lipid and Advanced Glycation End Products (AGEs)
Animals were weighed every week. FBG, total cholesterol (TC),
triglyceride (TG) levels were determined by DVI-1650 Automatic
Biochemistry and Analysis Instrument (Bayer, Germany). Serum
AGEs specific fluorescence determinations were performed by
measuring emission at 440 nm on excitation at 370 nm using a
fluorescence spectrophotometer (HITACHI F-2500, Japan) at the
end of the treatment.
Proteomic Analysis
Mass spectrometric analysis of iTRAQ samples. Mass
spectrometric analysis was performed using a micro liquid
chromatography system (MDLC, GE Healthcare) and a LTQ-
Velos ion trap mass spectrometer (Thermo Finnigan, San Jose,
CA, USA). The separation column was a 0.15 mm6150 mm
capillary packed with Zorbax 300SB-C18particles (Agilent Tech-
nologies). Mobile phase A (0.1% formic acid in water) and the
mobile phase B (0.1% formic acid in ACN) were selected. The
volumetric flow rate in the separation column was set to about
1 ml/min, with a 2 h long separation gradient running from 0% to
100% B.
Mass spectrometric data were acquired using data-dependent
acquisition conditions: each MS event was followed by zoom/MS2
scans on the five top-most intense peaks; zoom scan width was
65 m/z; dynamic exclusion was enabled at repeat count 1, repeat
duration 30 s, exclusion list size 200, exclusion duration 60 s, and
exclusion mass width 61.5 m/z; PQD parameters were set at
isolation width 2 m/z, normalized collision energy 35%, activa-
tion Q 0.7, and activation time 0.1 ms; the threshold for MS/MS
acquisition was set to 500 counts.
Data analysis. For protein identification and statistical
validation, the acquired MS/MS spectra were automatically
searched against the non-redundant International Protein Index
(IPI) mouse protein database (version 3.72) using the Turbo
SEQUEST program in the BioWorksTM 3.1 software suite. The
database search parameters included the following settings:
number of allowed missed tryptic cleavage sites was set to 2, the
peptide tolerance was 2 u, the fragment ion tolerance was 1 u, and
only fully tryptic fragments were considered for peptide selection.
The sensitivity threshold and mass tolerance for extracting the
iTRAQ ratios were set to 1 and 60.5, respectively. Data filtering
parameters were chosen to generate false positive protein
identification rates of ,1%, as calculated by searching the MS2
scans against a forward reversed database of proteins. A threshold
was set to 1.5 with a P-value ,0.05 yielding at least a 50% change
in abundance compared to the reference (CC group).
Subcellular localization analysis and functional
classification. The localization analysis of the identified
proteins in aortas was performed by using AmiGO (Version 1.8).
We get the details including the information of subcellular
localization by manual input the name of these proteins.
Sequences of all identified proteins by iTRAQ were submitted
to KOGnitor for KOG (eukaryotic orthologous groups) classifica-
tion (http://www.ncbi.nlm.nih.gov/COG/grace/kognitor.html)
[16]. When we manual input an identified protein sequence, it
can be assigned with a KOG number. A KOG number belongs to
one category. The protein ratio for each category was calculated
by dividing the number of proteins within a category by the sum of
assigned proteins from all categories.
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Protein network analysis. The global protein changes data
in the aorta of db/db mice treatment with GSPB2 were analyzed
through the use of Ingenuity Pathways Analysis (Ingenuity
Systems, CA). This program uses a knowledge database derived
from literature to relate gene products based on their interaction
and function. The proteins with their abundance change and
corresponding Swiss-Prot accession numbers were imported into
the program. Ingenuity software uses the data to navigate the
Ingenuity pathways database for interactions between these focus
proteins and all the other protein stored in the database to
generate biological networks. A score better than 2 is usually
considered as a valid network.
ELISA of Serum MFG-E8 in the Patients with T2DM
Human studies. Fifty five elderly patients with T2DM (mean
age 69.3667.44 years) were registered as outpatients in the
Department of Geriatrics of Qi-Lu Hospital of Shandong
University, China. The inclusion criteria were the presence of
T2DM according to the 1999 diagnostic guidelines of the World
Health Organization (WHO), given routine pharmacotherapy
with an oral hypoglycemic agent and/or insulin for at least one
year. We excluded patients who had a history of alcohol abuse,
evidence of liver disease, or severe cardiac problems and dialysis.
All patients signed informed consent. The study protocol was
approved by Qi-Lu Hospital of Shandong University Ethics Board
and was conducted according to the Declaration of Helsinki
(1964). CF-PWV was measured by an automatic device (Com-
plior, France).
ELISA of MFG-E8 in human serum. A 96-well microplate
(NUNC plate) was coated with 0.2 mg/well of monoclonal anti-
human lactadherin antibody (R&D Systems) in PBS buffer
(pH 7.4, 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4,
1.5 mM KH2PO4). A 100 mL of human serum sample in diluent
(1% BSA in PBS, pH7.4) buffer was added to each well. After an
incubation period of 2 h at room temperature, the wells were
aspirated and washed with wash buffer (0.05% Tween 20 in PBS,
pH 7.4). Each well was then incubated with 2 mg/mL lactadherin
(rabbit polyclonal IgG from Santa Cruz) in diluent buffer for 2 h at
room temperature, washed as above and incubated with 0.4 mg/
mL of goat anti rabbit IgG-HRP (Santa Cruz) for 20 min at room
temperature. HRP activity was determined using a microplate
reader set to 450 nm with 570 nm wavelength correction.
Recombinant human lactadherin (R&D systems) was used to
prepare the standard curve.
Treatment of MFG-E8 RNAi and Recombinant MFG-E8 in
db/db Mice
Primary culture of aortic endothelial cell. The aorta of
male C57BLKS/J db/m mice was isolated. Longitudinal dividing
the aortic wall and cut into small pieces, stick the lining surface in
the cell culture flasks. Then put it in the incubator with endothelial
cell medium (ECM, ScienCell) with an atmosphere of 5% CO2/
Figure 1. Effects of GSPB2 on body weight, FBG, AGEs, TG and TC in db/db mice. A: Body weight changes of the mice. B: FBG changes of
the mice. C: Measurement of AGEs 10 weeks after initiation of the experiment. D: Measurement of serum TG and TC 10 weeks after initiation of the
experiment. **P,0.01 compared with CC group; ##P,0.01 compared with DM group. CC: control db/m group; DM: untreated db/db group; DMT:
GSPB2 treated db/db group. GSPB2: grape seed procyanidin B2; FBG: fasting blood glucose; AGEs: advanced glycation end products; TG: triglyceride;
TC: total cholesterol.
doi:10.1371/journal.pone.0052541.g001
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95% air. After 7–9 days, cell fused into a single layer, dealt with
0.25% trypsin digestion and passage. Cells from passages 3 to 6
were used in this study.
Construction of MFG-E8 RNAi and endothelial cell
transfection. Lentiviral vector with short hairpin RNAs
(shRNAs) for MFG-E8 were designed and chemically synthesized
from Shanghai GeneChem Co., Ltd (Shanghai, China). The
lentiviral vector with shRNA sequence targeting MFG-E8




TGCCCTGATTATCCAGC-39. The lentiviral vector with
green fluorescence protein (GFP) was used as the RNAi control.
Aortic endothelial cell were transfected with lentiviral vectors at
a multiplicity of infection (MOI = 100) according to the manufac-
turer’s instructions. Fluorescence microscope was used to measure
transfection efficiency at time points of 12, 24, 48 and 72 hours
after transfection. The most effective target site of RNA
interference was confirmed by using western blotting for the
expression levels of MFG-E8 after 3 days.
Animals and groups. Male C57BLKS/J db/db and db/m
mice (n = 40, 7 weeks old) were used in this study. C57BLKS/J
db/m mice were selected as control group (CC, n = 8). The db/db
mice were divided into 4 groups: an untreated diabetic group
(DM, n = 8), LV-GFP treated db/db group (GFP, n = 8), MFG-E8
RNAi treated db/db mice group (M-RNAi, n = 8) and recombi-
nant MFG-E8 treated db/db mice group (rmMFG-E8, n = 8).
Each group of mice was observed from week 13 to week 18
without any administration of hypoglycemic therapy. At the end of
the intervention, all mice were fasted overnight and then
sacrificed. Fasting blood was collected, and the aortas were
dissected. Aortic tissues and sera were kept at 280uC until further
analysis.
Figure 2. Subcellular localization, functional classification analysis and ingenuity pathway analysis of the identified differential
proteins between untreated db/db mice and GSPB2 treated db/db mice. A: Subcellular localization by AmiGO analysis of the identified
differential proteins between untreated db/db mice and GSPB2 treated db/db mice. B: Functional classification by KOG analysis of the identified
differential proteins between untreated db/db mice and GSPB2 treated db/db mice. C and D: Ingenuity pathway analysis (score 46) based on the
differentially expressed aortic proteins between untreated db/db mice and GSPB2 treated db/db mice. Protein nods with colored background
correspond to the identified proteins. GSPB2: grape seed procyanidin B2.
doi:10.1371/journal.pone.0052541.g002
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Treatment of MFG-E8 RNAi and recombinant MFG-E8 in
db/db mice. After testing knockdown efficiencies of the four
shRNA sequences by using aortic endothelial cells, the most
efficient sequences targeting MFG-E8 or LV-GFP was diluted to a
total volume of 300 ul containing 46107 TU was injected into the
tail vein of fourteen-week-old male db/db mice. Recombinant
mouse MFG-E8 (R&D Systems) was diluted in PBS and 300 ul of
the solution (20 ug/kg) was injected through the tail vein of
fourteen-week-old male db/db mice twice a week for 4 weeks.
After 4 weeks of treatment, each mouse of M-RNAi group, GFP
group and rmMFG-E8 group was perfused with ice-cold
physiological saline (0.9% NaCl, pH 7.4) after cardiac puncture,
and the aortas were excised, placed in liquid nitrogen, and stored
at 280uC until analysis.
Morphology Examination
Aortas were fixed in 4% paraformaldehyde and embedded in
paraffin, and 5 mm thick sections were cut. Then stained with
hematoxylin-eosin and examined by light microscopy. The intima-
media thickness was measured using Image Proplus 6.0.
Part of aorta was fixed in 3% glutaraldehyde in cacodylate
buffer at 4uC for 2 h and subsequently post fixated in a 1%
osmium-tetroxide phosphate buffer solution for 1 h. Next, the
samples were dehydrated in a graded ethanol series with acetone,
permeated, and embedded in epoxide resin. Ultrathin sections
were stained with uranylacetate and lead citrate, and examined
under an H-800 electron microscope (TEM, Hitachi Electronic
Instruments, Tokyo, Japan).
Western Blotting Analysis
Western blotting analysis was performed on samples of aortas
obtained from six groups of mice. Equal amount of proteins were
separated by electrophoresis in a SDS-polyacrylamide gel. After
the proteins were transferred onto a polyvinylidene difluoride
membrane, the blot was incubated with blocking buffer (5% non-
fat dry milk and 0.05% Tween 20 in TBS) for 1 h at room
temperature and then probed with antibody for MFG-E8 (1:1000
dilution; R&D), phosphorylated ERK1/2 (1:1000 dilution; Cell
Signaling), CSRP1 (1:1000 dilution; Abcam) and GSTT1 (1:1000
dilution; Santa Cruz) overnight at 4uC. After incubation in
horseradish peroxidase-conjugated secondary antibody, the im-
Figure 3. Correlation between serum MFG-E8 and CF-PWV in T2DM patients (n = 55). MFG-E8: milk fat globule epidermal growth factor-8;
CF-PWV: carotid- femoral pulse wave velocity.
doi:10.1371/journal.pone.0052541.g003
Figure 4. GFP transfection in aortic endothelial cells and aorta of db/db mice. A: Fluorescence micrograph displays GFP in aortic
endothelial cells (6200). B: Fluorescence micrograph displays GFP in aorta of db/db mice (6200).
doi:10.1371/journal.pone.0052541.g004
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munoblots were visualized with ECL immunoblotting detection
system, then stripped and reprobed with antibody recognizing b-
actin (1:1000 dilution; Cell Signaling), ERK1/2 (1:1000 dilution;
Cell Signaling) and GAPDH (1:1000 dilution; Cell Signaling) to
ensure equal loading. The intensity of each protein band was
quantified with densitometric analysis.
ELISA of MCP-1 in db/db and db/m Mice Serum
A 96-well microplate was coated with monoclonal antibody to
mouse MCP-1 (eBioscience). A 100 mL of mouse serum sample in
diluent buffer was added to each well. After an incubation period
of 2 h at room temperature, the wells were aspirated and washed
with wash buffer. A biotin-conjugated anti-mouse MCP-1
antibody was added and binds to mouse MCP-1 captured by
the first antibody, then washed as above and incubated with
streptavidin-HRP for 1 h at room temperature. Following
incubation unbound Streptavidin-HRP was removed during a
wash step, and substrate solution reactive with HRP was added to
the well. A colored product was formed in proportion to the
amount of mouse MCP-1 present in the mouse serum sample. The
reaction was terminated by addition of acid and absorbance was
measured at 450 nm. A standard curve was prepared from 7
mouse MCP-1 standard dilutions and mouse MCP-1 sample
concentration determined.
Statistical Analysis
Data were expressed as mean 6 standard deviation. Statistical
analysis between groups was made using one-way analysis of
variance (ANOVA) followed by Tukey’s HSD test for multiple
comparisons. P-value ,0.05 was considered statistically signifi-
cant. All analyses were performed with SPSS for Windows
software version 10.0 (SPSS, Chicago, USA).
Results
Effects of GSPB2 on Body Weight, FBG, AGEs, TG and TC
Mice were maintained over the length of this study without any
hypoglycemic treatments. Figure 1A shows body weight among
the control, untreated and GSPB2-treated diabetic mice. The
body weight of diabetic mice was significantly higher than that of
the control mice at 8 weeks, 12 weeks, 16 weeks, and 18 weeks
(P,0.01). GSPB2 significantly decreased the body weight of
diabetic mice at 12 weeks, 16 weeks, and 18 weeks (P,0.01).
Figure 1B shows FBG among the control, untreated and GSPB2-
treated diabetic mice. The FBG of diabetic mice was significantly
higher than the control mice at 8 weeks, 12 weeks, 16 weeks, and
18 weeks (P,0.01), but GSPB2 did not decrease FBG at 8, 12, 16,
and 18 weeks (P.0.05). The serum AGEs, TG and TC of diabetic
mice at 18 weeks were higher than those of the control mice
(P,0.01). GSPB2 significantly reduced the serum AGEs, TG and
TC of diabetic mice (P,0.01) (Figure 1C, 1D).
Quantification and Identification of the Aortic Proteome
by iTRAQ Analysis
To further investigate the effects of GSPB2 on db/db mice, we
used iTRAQ to generate the protein expression profiles of four
aorta samples per group. In total, 557 proteins were shown to have
significantly different abundance between control group and DM
group (61.5-fold). Of these 557 proteins, the levels of 139 proteins
were normalized by GSPB2 treatment. Table S1 showed the
proteins identified, including the name, accession number,
function, molecular weight, PI, and protein expression ratio. In
brief, the differentially expressed proteins that were normalized by
GSPB2 were related to many important biological functions
including oxidative stress, metabolism, apoptosis, tissue remodel-
Figure 5. Representative light micrographs of the aorta (hematoxylin-eosin; 6200). A: Effects of GSPB2 on the aorta of db/db mice. B:
Effects of MFG-E8 RNAi on the aorta of db/db mice. C: Effects of recombinant MFG-E8 on the aorta of db/db mice. Statistical results of intima-media
thickness were shown in bar graph. **P,0.01 compared with CC group; ##P,0.01 compared with DM or GFP group. CC: control db/m group; DM:
untreated db/db group; DMT: GSPB2 treated db/db group; GFP: treatment of GFP in db/db group; M-RNAi: treatment of MFG-E8 RNAi in db/db
group; rmMFG-E8: treatment of recombinant MFG-E8 in db/db group.
doi:10.1371/journal.pone.0052541.g005
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ing, and heat shock. MFG-E8, the protein which we further
investigated, was increased by 2.4-fold in abundance in db/db
mice, which was normalized by GSPB2 treatment (protein
expression ratio: DMT/DM 0.59; DMT/CC 1.43). Eight unique
peptides from MFG-E8 were identified, and the cover percent of
protein was 22.46%.
Subcellular Localization Analysis, Bioinformatic
Functional Analysis and Ingenuity Pathway Analysis of
Differentially Abundant GSPB2 Associated Arterial
Proteins in db/db Mice
The localization analysis of the identified proteins in aorta using
AmiGO (Version 1.8) is shown in Figure 2A. Among these
proteins, some are located in one or more subcompartments of the
cell. 40% were in cytoplasm, 18.8% in nucleus, 12.1% in plasma
membrane, 7.9% in endoplasmic reticulum, 7.3% in mitochon-
drion, 6.7% in extracellular, 6% in centrosome, 3% in ribosome,
2.4% in Golgi, 1.2% in lysosome.
The functional classification of the identified proteins in aortas is
shown in Figure 2B. Among the functional assignment of the
proteins, 17% were involved in signal transduction mechanisms,
12% in cytoskeleton, 9% in posttranslational modification, protein
turnover, chaperones, 7% in translation, ribosomal structure and
biogenesis, 6% in intracellular trafficking, secretion, and vesicular
transport, 4% in cell cycle control, cell division, chromosome
partitioning, 4% in nucleotide transport and metabolism, 4% in
lipid transport and metabolism, and the remaining proteins were
identified as dispersed across 13 remaining categories.
Ingenuity Pathway Analysis (IPA) (http://www.ingenuity.com)
shows that the primary pathway involved was cell death, lipid
metabolism and small molecule biochemistry, where 16 of the
proteins could be linked together (Figure 2C). The proteins
include Isoform 1 of Apoptosis-inducing factor 2 (AIFM2),
Mitochondrial fission 1 protein isoform 2 (FIS1), Isoform 1 of
microtubule-actin cross-linking factor 1 (Macf1), Isoform 1 of
methylglutaconyl-CoA hydratase (AUH), Platelet isoform of
phosphofructokinase (PFKP), and so on. The expression of these
proteins was decreased in diabetic aorta, and was normalized by
GSPB2. Together with Interleukin 4 (IL-4), Interleukin 5 (IL-5),
Interferon-c (IFNc), Peroxisome proliferator-activated receptor-c
(PPARc), Leptin (LEP), Heat shock protein-90 (Hsp90), Trans-
forming growth factor-b (TGFb), and other molecules, the
differentially expressed proteins normalized by GSPB2 form a
network of cell death and lipid metabolism (Figure 2D). The
pathways would facilitate the understanding of diabetes biomark-
ers for further study.
Serum MFG-E8 in the Patients with T2DM
We examined the serum MFG-E8 of 55 T2DM patients by
using ELISA to determine the clinical significance of the
proteomic findings of the raised MFG-E8 in the aorta of db/db
Figure 6. Representative Electron Micrographs of the aorta (scale bar: 1 mm or 2 mm). A: Effects of GSPB2 on the aorta of db/db mice. B:
Effects of MFG-E8 shRNA on the aorta of db/db mice. C: Effects of recombinant MFG-E8 on the aorta of db/db mice. Black arrows show abnormal
ultrastructure changes. CC: control db/m group; DM: untreated db/db group; DMT: GSPB2 treated db/db group; GFP: treatment of GFP in db/db
group; M-RNAi: treatment of MFG-E8 shRNA in db/db group; rmMFG-E8: treatment of recombinant MFG-E8 in db/db group.
doi:10.1371/journal.pone.0052541.g006
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mice. We observed the increased serum MFG-E8 significantly
correlated with increased aortic stiffness measured by PWV (r
= 0.481, P,0.01) (Figure 3).
Transfection Efficiency with MFG-E8 RNAi
The aortic endothelial cells were treated with MFG-E8 RNAi or
lentivirus vector. Transfection conditions were optimized by using
different MOI and the transfection efficiency was assessed by
fluorescence microscope and western blotting. Aortic endothelial
cell carrying GFP was observed with fluorescence microscope
(Figure 4A). The transfection efficiency was about 95% at 72 hour
or longer (MOI = 100).
To investigate the transfection efficiency of RNAi in vivo, we
transfected db/db mice with lentiviral vector carrying GFP
injected into the tail vein. After 7 days, the aorta were excised
and observed by fluorescence microscope (Figure 4B).
Histological Findings
Under light microscopy, aortic remodeling and proliferation of
vascular smooth cells (VSMC) and endothelial injury were
observed in the aorta of db/db mice. Moreover, GSPB2 and
MFG-E8 RNAi suppressed the endothelial injury, aortic remod-
eling and proliferation of VSMC and led to light microscopic
findings similar to those of the control mice (Figure 5A and 5B). In
aorta of recombinant MFG-E8 protein-treated group, the
deteriorative changes were observed. The blood vessel was thicker,
characterized by more inflammatory cells infiltrated such as
neutrophil and lymphocyte and focal necrosis. Endothelial cell
swelling and perivascular inflammation were also observed
(Figure 5C).
Under electron microscopy, the impaired endothelial cells and
the rod-like mitochondria in endothelial cells were seen in aortic
tissue in the diabetic or GFP treated mice. Moreover, the rupture
of vascular elastic membrane and the increased collagen fibers
Figure 7. Effects of GSPB2, MFG-E8 RNAi and recombinant MFG-E8 on the expression of MFG-E8 in db/db mice by Western blotting
analysis. Data were expressed as the expression ratio of MFG-E8/b-actin and given as mean 6 SD from three experiments. **P,0.01, *P,0.05
compared with CC group; ##P,0.01 compared with DM or GFP group. CC: control db/m group; DM: untreated db/db group; DMT: GSPB2 treated
db/db group; GFP: treatment of GFP in db/db group; M-RNAi: treatment of MFG-E8 shRNA in db/db group; rmMFG-E8: treatment of recombinant
MFG-E8 in db/db group.
doi:10.1371/journal.pone.0052541.g007
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were observed in the diabetic aorta. Many smooth muscle cells
showed pyknotic nucleus, increased heterochromatin, mitochon-
drial condensation, swelling of the endoplasmic reticulum, and
many autophagosome appeared, whereas normal ultrastructure
was observed in the aortic tissue of the control db/m mice. GSPB2
and MFG-E8 RNAi tended to improve the preservation of the fine
structure of aortic tissue (Figure 6A and 6B), but in the rmMFG-
E8 group, the deteriorative changes and the migration of smooth
muscle cells in the vascular elastic membrane were observed
(Figure 6C).
Effects of GSPB2, MFG-E8 RNAi and Recombinant MFG-E8
on the Expression of MFG-E8 in db/db Mice
In order to confirm the results of iTRAQ, the protein expression
of MFG-E8 in the aorta of control db/m mice, untreated db/db
mice, and GSPB2 treated db/db mice was carried out by Western
blotting analysis. The protein expression of MFG-E8 in db/db
mice were significantly higher than that of control db/m mice
(P,0.01); after treatment with GSPB2, the expression of MFG-E8
was decreased compared to that of untreated db/db mice
(P,0.01), which was in accordance with the result of iTRAQ
(Figure 7A and 7B).
Western blotting analysis showed protein expression of MFG-
E8 in GFP group was significantly higher than that of control db/
m group (P,0.01); after treatment with MFG-E8 RNAi, the
expression of MFG-E8 decreased compared to GFP treated db/db
mice (Figure 7C and 7D), which confirmed the transfection
efficiency in db/db mice in vivo.
Figure 7E and 7F show the recombinant MFG-E8 on the
protein expression in db/db mice. The protein expression of
MFG-E8 in db/db mice was significantly higher than that of
control db/m mice (P,0.01); however, the rmMFG-E8 group
Figure 8. Effects of GSPB2, MFG-E8 RNAi and recombinant MFG-E8 on the expression of p-ERK in db/db mice by Western blotting
analysis. Data were expressed as the expression ratio of p-ERK/total-ERK and given as mean 6 SD from three experiments. **P,0.01, *P,0.05
compared with CC group; ##P,0.01 compared with DM or GFP group. CC: control db/m group; DM: untreated db/db group; DMT: GSPB2 treated
db/db group; GFP: treatment of GFP in db/db group; M-RNAi: treatment of MFG-E8 shRNA in db/db group; rmMFG-E8: treatment of recombinant
MFG-E8 in db/db group.
doi:10.1371/journal.pone.0052541.g008
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displayed increased expression of MFG-E8 compared to that of
both control db/m group and DM group (P,0.01).
Effects of GSPB2, MFG-E8 RNAi and Recombinant MFG-E8
on ERK1/2 Phosphorylation Levels in db/db Mice
To understand the mechanism of atherosclerosis in T2DM, we
further examined the ERK1/2 phosphorylation (p-ERK1/2) in
aorta of db/db mice by Western blotting. The expression of p-
ERK1/2 in db/db mice were higher than that of control db/m
mice (P,0.05); after treatment with GSPB2, the expression of p-
ERK1/2 was decreased compared to that of untreated db/db
mice (Figure 8A and 8B). MFG-E8 RNAi decreased in the
phosphorylated ERK1/2 (P,0.01) (Figure 8C and 8D). Treat-
ment with recombinant MFG-E8 increased ERK1/2 phosphor-
ylation (P,0.01) (Figure 8E and 8F).
Effect of GSPB2, MFG-E8 RNAi and Recombinant MFG-E8
on the Levels of MCP-1 in db/db Mice
Figure 9 shows the effects of GSPB2, MFG-E8 RNAi and
recombinant MFG-E8 on the expression of MCP-1 in serum of
db/db mice by ELISA. The expression of MCP-1 in serum was
significantly increased in DM group compared with that of control
group (P,0.01). GSPB2 and MFG-E8 RNAi decreased the level
of MCP-1 (P,0.01) (Figure 9A and 9B). Recombinant MFG-E8
significantly increased the expression of MCP-1 (P,0.01)
(Figure 9C).
Validation of iTRAQ Data on Other Selected Proteins
To validate the proteomic analysis of aorta using iTRAQ we
performed, CSRP1 and GSTT1 were validated using western
blotting analysis. CSRP1 was found to be inhibited whereas
GSTT1 was enhanced in the DMT group compared to the DM
group (Figure S1). The significance of those proteins would be
interesting topic for our future studies.
Discussion
Atherosclerotic diseases are among the major complications of
T2DM leading to morbidity and mortality. The mechanism
underlying atherogenesis in T2DM has been under extensive
investigation. Studies have shown that oxidative stress plays a key
role in this process [17–20]. Reactive oxygen species (ROS) can
lead to damage of endothelial cells and to proliferation, migration
and phenotypic change of smooth muscle cells, contributing to
atherogenesis in the setting of DM [21,22].
GSPE has potent antioxidant effects [23–28]. Studies have
shown that GSPE have anti-atherosclerotic effects both in animals
and human subjects, which has been closely correlated with its
antioxidant potency [29]. Our previous studies showed that GSPE
demonstrated anti-non-enzymatic glycation and anti-inflammato-
ry effects in DM animal models [30,31]. GSPB2 is one of the main
components of GSPE. Our studies showed that GSPB2 has
protective effects against early stage endothelial dysfunction in
DM.We also reported for the first time, to the best of our
knowledge, that GSPB2 inhibited the AGE-induced proliferation
and migration of human aortic smooth muscle cells (HASMCs)
through inhibiting the nuclear translocation of nuclear factor-kB
and the degradation of its inhibitor, IkB-a [15]. Notwithstanding
the extensive molecular studies the data regarding the proteomic
profile of aorta in DM and the effect of pharmacological
intervention with respect to the proteomic changes has been
scarce.
In this study, our results showed that GSPB2 significantly
prevented the development of obesity in db/db mice during the
18-week experimental period. GSPB2 also prevented the elevation
in the levels of serum AGEs observed in db/db mice, suggesting an
anti-non-enzymatic glycation effect of GSPB2. Our in vivo data
showed that GSPB2 inhibited hyperlipidemia in db/db mice.
VSMC proliferation and endothelial cell damage were suppressed
by GSPB2 in the aortic wall of db/db mice (Figure 5 and 6).
Although the glucose level was not significantly decreased by the
administration of GSPB2 [32], a tendency to reduce the glucose
level was observed.
iTRAQ was used to investigate aorta protein profiles among
db/m, untreated db/db, and GSPB2 treated db/db mice. More
than 1500 proteins were detected, of which 557 demonstrated
significant changes in the expression levels in DM aorta, and 139
proteins of them were normalized by GSPB2 administration.
Some proteins contributing to cytoskeletal of the vasculature
were found up-regulated in the aorta of db/db mice and down-
Figure 9. Effects of GSPB2, MFG-E8 RNAi and recombinant
MFG-E8 on the expression of MCP-1 in serum of db/db mice by
ELISA. **P,0.01 compared with CC group; ##P,0.01 compared with
DM or GFP group. CC: control db/m group; DM: untreated db/db
group; DMT: GSPB2 treated db/db group; GFP: treatment of GFP in db/
db group; M-RNAi: treatment of MFG-E8 shRNA in db/db group;
rmMFG-E8: treatment of recombinant MFG-E8 in db/db group.
doi:10.1371/journal.pone.0052541.g009
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regulated in the aorta of GSPB2-treated db/db mice. CSRP1 is
expressed primarily in VSMCs and in sensing or responding to
pathological vascular stress and maintaining smooth muscle
homeostasis [33]. It is thought to be critical for smooth muscle
differentiation. Our results suggested that the inhibition of CSRP1
partly contributed to the improvement of aortic damage.
Moreover, it is well known that increased oxidative stress has
been implicated in the pathogenesis of diabetic vascular compli-
cations of type 2 diabetes [34]. Our data showed that glutathione
S-transferase, theta 1 (GSTT1), an enzyme actively involved in
alleviating oxidative stress was down-regulated in the db/db mice
aorta which was reversed by GSPB2 treatment. GSTT1 is
associated with the regulation of inflammation through modula-
tion of prostaglandin signaling pathways and oxidative stress [35].
Decreased GSTT1 expression contributes to increased oxidative
stress in the db/db mice.
MFG-E8, also known as lactadherin, plays an important role in
the pathogenesis of diabetic vascular-related process. In aorta,
MFG-E8 is a protein mainly expressed by adventitial microvessels,
medial smooth muscle cells and luminal endothelial cells [36]. Our
previous proteomic studies showed that the expression of MFG-E8
in the aorta of type 1 diabetic rats was significantly higher than in
control rats and treatment with GSPE significantly inhibited the
expression of MFG-E8 in diabetic rats [37], suggesting that MFG-
E8 was involved in oxidative stress and inflammatory process in
diabetic aortic disease. MFG-E8 was up-regulated with increased
oxidative. It has recently been reported that high concentration of
glucose up-regulated MFG-E8 in the adiposomes, increased ROS
production [38]; ROS scavenger N-acetyl cysteine decreased
MFG-E8 in the adiposomes. Expression of MFG-E8 was up-
regulated in epididymal adipose tissues of diet-induced obese
C57BL/6 mice as well as in those of the genetically obese ob/ob
and db/db mice [39–41]. In this study we found that MFG-E8
protein was increased by 2.4-fold in abundance in db/db mice as
compared with db/m mice, which was reversed by GSPB2
treatment. Given the increased aortic expression of MFG-E8 in
both type 1 and 2 diabetic animal models, we further investigated
the significance of MFG-E8 in the development of atherosclerosis
in DM as a target of GSPB2 among the identified differential
proteins.
Inhibition of MFG-E8 expression by RNAi significantly
reduced whereas exogenous administration of recombinant
MFG-E8 promoted the pathological processes involved in
atherogenesis in db/db mice, including endothelial cell injury,
VSMC proliferation and aortic remodeling (see Figure 5 and 6).
Interestingly we also found that serum MFG-E8 level is positively
correlated with increased PWV in T2DM patients, the increase of
which is a well-established parameter for increased arterial
stiffness. This finding is consistent with our previous data that
serum MFG-E8 level was elevated in diabetic patients as
compared with that in healthy subjects [42].
ERK1/2 activation has been reported to play a pivotal role in
cell replication in the arterial wall after injury [43], and associated
with the proliferation of HASMCs [44]. ERK1/2 activation/
phosphorylation is also involved in the increased production of
reactive oxygen species and the toxic effects of AGEs, processes
involved in atherogenesis in DM [45,46]. The present study
showed that ERK1/2 phosphorylation expression was suppressed
in aorta of GSPB2-treated mice. Targeted inhibition of MFG-E8
by RNAi suppressed while exogenous recombinant MFG-E8 led
to increased ERK1/2 phosphorylation. We also found that
GSPB2 treatment reduced serum level of MCP-1, a potent
chemokine in the pathogenesis of inflammation and atherosclerosis
[47,48], in the db/db mice as a result of inhibition of MFG-E8.
Circulating MCP-1 has been implicated as causative factors in the
development of T2DM. MCP-1 activates ERK1/2 in endothelial
cells and pancreatic b cells [49–51]. These findings demonstrate
that MFG-E8 induces atherosclerosis in db/db mice through
ERK1/2 and MCP-1 signaling pathways. Therefore, further
studies are needed to clarify the cross-talk and mechanism between
these biomarkers. Although GSPB2 is a well-studied antioxidant,
whether and how the inhibitory effect of GSPB2 on atherosclerosis
in db/db mice is related to its antioxidative effects will be the topic
of our studies to come.
Conclusion
In conclusion, our study shows that MFG-E8 plays an
important role in the early arterial damages in atherogenesis in
diabetes. GSPB2 inhibits atherogenesis in db/db mice, at least in
part, due to its inhibition of aortic expression and serum level of
MFG-E8. Measuring MFG-E8 serum level could be a useful
clinical surrogate prognosticating atherogenesis in DM patients.
Approaches targeting MFG-E8 including use of GSPB2 could
potentially lead to new modality in the prevention and treatment
of vascular complications in DM patients.
Supporting Information
Figure S1 Western blotting validation of iTRAQ data on other
two proteins: CSRP1 and GSTT1. GAPDH was used as the
loading control. CC: control db/m group; DM: untreated db/db
group; DMT: GSPB2 treated db/db group. **P,0.01 compared
with CC group; ##P,0.01 compared with DM group.
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